AI assistant
Sabre Insurance Group PLC — Director's Dealing 2019
Oct 15, 2019
5341_dirs_2019-10-15_edfbc325-4b03-43bc-be6e-86db765ee1d8.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9136P
Sabre Insurance Group PLC
15 October 2019
15 October 2019
Sabre Insurance Group plc
Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Sabre Insurance Group plc (the "Company" or "Sabre"), one of the UK's leading private motor insurance underwriters, announces that it was notified on 14 October 2019 that both James Ockenden, Chief Actuary, sold 38,636 Ordinary Shares of 0.01 pence each in the capital of the Company and his wife, Rebecca Ockenden sold 4,050 Ordinary Shares of 0.01 pence each in the capital of the Company at an average price of 291.83 pence per Ordinary Share (the "Transaction"). Following the Transaction, Mr Ockenden transferred 19,050 Ordinary Shares of 0.01 pence each in the capital of the Company on 14 October 2019 to Mrs Ockenden.
Following the transaction, Mr Ockenden and Mrs Ockenden, together hold 940,000 Ordinary Shares in the Company, representing 0.38 per cent. of the Company's issued share capital.
Further details of the Transaction are set out below and in the attached notification as required by the EU Market Abuse Regulation.
For further information, please contact:
Anneka Kingan - Company Secretary
LEI Code: 2138006RXRQ8P8VKGV98
Notification of transactions by Persons Discharging Managerial Responsibilities (PDMR)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
James and Rebecca Ockenden
2
Reason for the notification
a)
Position/status
Chief Actuary and spouse
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volume(s)
| Price per share | Volume |
| £2.9183 | 42,686 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 42,686 | £2.9183 |
e)
Date of transaction
14 October 2019
f)
Place of transaction
London Stock Exchange (XLON)
Notification of transactions by Persons Discharging Managerial Responsibilities (PDMR)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
James Ockenden
2
Reason for the notification
a)
Position/status
Chief Actuary
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Sabre Insurance Group Plc
b)
LEI
2138006RXRQ8P8VKGV98
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares
Identification code
GB00BYWVDP49
b)
Nature of the transaction
Transfer of shares to Mrs R Ockenden (spouse) for nil consideration
c)
Price(s) and volume(s)
| Price per share | Volume |
| Nil | 19,050 |
d)
Aggregated Information
Volume
Price
| Volume | Price per share |
| 19,050 | Nil |
e)
Date of transaction
14 October 2019
f)
Place of transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHKELBFKBFBFBL